Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · vice president | September 28, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 32,840 |
Ending reported balance
After 2026-09-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-28 · Exercise / conversion · Acquired 4,629 · Balance 37,110 Row 2 · 2026-09-28 · Tax withholding · Disposed 4,270 · Balance 32,840 F1: Payment of purchase price and tax obligation on stock option exercise. |
| Stock Option (right to buy with tandem tax withholding)SEC Table II · derivative / convertible security · Conversion / exercise price $445.35 · Expires 2026-10-28 | Direct | 22,089 |
Reported balance
After 2026-09-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-28 · Exercise / conversion · Disposed 4,629 · Balance 22,089 F2: Vesting in three equal annual installments commencing 10/28/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Payment of purchase price and tax obligation on stock option exercise.
F2: Vesting in three equal annual installments commencing 10/28/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 29, 2026 14:51 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 4,629 | $445.35 Strike: $445.35 | $2,061,525.15 |
DisclosureSEC source: 0001193125-26-406299 · ownership.xml · derivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,089 Underlying: Capital Stock · 4,629 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| September 28, 2026 Filed Sep 29, 2026 14:51 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 4,270 | $506.65 | $2,163,395.50 |
DisclosureSEC source: 0001193125-26-406299 · ownership.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,840 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| September 28, 2026 Filed Sep 29, 2026 14:51 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 4,629 | $445.35 | $2,061,525.15 |
DisclosureSEC source: 0001193125-26-406299 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 374 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 6 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 988 Underlying: Capital Stock · 374 shares Expires not disclosed F7 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F8 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F8 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 5 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614 Underlying: Capital Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F6 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 4 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774 Underlying: Capital Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F6 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 72 | $469.56 | $33,808.32 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,481 F4 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 199 | $469.56 | $93,442.44 |
DisclosureSEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. F2 · balance_after: Administrative error from 8/7/24 filing; previous holdings were ouverstated by 673 shares Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:12 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 6,338 | $443.79 Strike: $443.79 | $2,812,741.02 |
DisclosureSEC source: 0001193125-25-246785 · ownership.xml · derivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,718 Underlying: Capital Stock · 6,338 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · derivative · entry 6 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 934 Underlying: Capital Stock · 320 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · derivative · entry 5 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614 Underlying: Capital Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · derivative · entry 4 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770 Underlying: Capital Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 149 | $553.39 | $82,455.11 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,027 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 96 | $553.39 | $53,125.44 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2022 through December 31, 2024, compared to a defined peer group of companies. The Company's performance ranked in the 31.3 percentile of that group, yielding an award of 60.4%; including the reinvestment of dividends paid during such period, the award is 61.0% of target. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 315 | $553.39 | $174,317.85 |
DisclosureSEC source: 0000950170-25-022191 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performace stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2022 through December 31, 2024. The actual performance of $64.97 exceeded the maximum payout threshold of $63.75 and therefore yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 19:47 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 4,523 | $597.70 Strike: $597.70 | $2,703,397.10 |
DisclosureSEC source: 0000950170-24-116618 · ownership.xml · derivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,380 Underlying: Capital Stock · 4,523 shares Expires 2029-10-22 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/22/2025 Read SEC document |
| August 07, 2024 Filed Aug 12, 2024 15:57 UTC Amendment | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 4,827 | $576.32 | $2,781,896.64 |
DisclosureSEC source: 0000950170-24-095219 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,765 F1 · date: Amended filing due to administrative error Read SEC document |
| August 06, 2024 Filed Aug 9, 2024 17:56 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 4,827 | $576.32 | $2,781,896.64 |
DisclosureSEC source: 0000950170-24-094535 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,765 Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 2,000 | $471.74 Strike: $471.74 | $943,480.00 |
DisclosureSEC source: 0000950170-24-027761 · ownership.xml · derivative · entry 9 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,857 Underlying: Capital Stock · 2,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 1,267 | $413.19 Strike: $413.19 | $523,511.73 |
DisclosureSEC source: 0000950170-24-027761 · ownership.xml · derivative · entry 8 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,857 Underlying: Capital Stock · 1,267 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:59 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 2,673 | $633.58 | $1,693,559.34 |
DisclosureSEC source: 0000950170-24-027761 · ownership.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,919 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 2,000 | $471.74 | $943,480.00 |
DisclosureSEC source: 0000950170-24-027761 · ownership.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 1,267 | $413.19 | $523,511.73 |
DisclosureSEC source: 0000950170-24-027761 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Share Units · Derivative | 294 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · derivative · entry 10 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 926 Underlying: Capital Stock · 294 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Chemed Capital Stock. F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · derivative · entry 9 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632 Underlying: Capital Stock · 134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · derivative · entry 8 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 766 Underlying: Capital Stock · 134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 77 | $586.49 | $45,159.73 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,325 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 126 | $586.49 | $73,897.74 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2021 through December 31, 2023 compared to a defined peer group of companies. The Company's performance ranked in the 47th percentile of that group, yielding an award of 92.6%; including the reinvestment of dividends paid during such period, the award is 93.4% of target. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:49 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 84 | $586.49 | $49,265.16 |
DisclosureSEC source: 0000950170-24-017063 · ownership.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2021 through December 31, 2023. The actual performance of 5.47% yielded an award of 61.7% of target; including the reinvestment of dividends paid during such period, the award is 62.2% of target. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 14:38 UTC | CHEMED CORP CHE · Entity 3723 | Giftcapital stock | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054585 · doc4.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,192 Read SEC document |
| October 25, 2023 Filed Oct 26, 2023 17:12 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 4,522 | $509.46 Strike: $509.46 | $2,303,778.12 |
DisclosureSEC source: 0001209191-23-053631 · doc4.xml · derivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,124 Underlying: capital stock · 4,522 shares Expires 2028-10-25 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/25/2024. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · derivative · entry 10 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Underlying: capital stock · 320 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 103 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · derivative · entry 9 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580 Underlying: capital stock · 103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 103 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · derivative · entry 8 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683 Underlying: capital stock · 103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 112 | $515.12 | $57,693.44 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,953 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 118 | $515.12 | $60,784.16 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2020 through December 31, 2022, compared to a defined peer group of companies. The Company's performance ranked in the 55.6th percentile of that group, yielding an award of 113.89%; including the reinvestment of dividends paid during such period, the award is 115% of target. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 208 | $515.12 | $107,144.96 |
DisclosureSEC source: 0001209191-23-011543 · doc4.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2020 through December 31, 2022. The actual performance of 12.67% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202% of target. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 15:17 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 2,533 | $413.19 Strike: $413.19 | $1,046,610.27 |
DisclosureSEC source: 0001209191-22-059000 · doc4.xml · derivative · entry 7 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,602 Underlying: capital stock · 2,533 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 15:17 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 2,212 | $515.25 | $1,139,733.00 |
DisclosureSEC source: 0001209191-22-059000 · doc4.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,739 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 15:17 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,533 | $413.19 | $1,046,610.27 |
DisclosureSEC source: 0001209191-22-059000 · doc4.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2022 Filed Nov 16, 2022 19:29 UTC | CHEMED CORP CHE · Entity 3723 | Giftcapital stock | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057264 · doc4.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,418 Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 14:40 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 4,489 | $462.04 Strike: $462.04 | $2,074,097.56 |
DisclosureSEC source: 0001209191-22-055184 · doc4.xml · derivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,135 Underlying: capital stock · 4,489 shares Expires 2027-10-31 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · derivative · entry 10 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Underlying: capital stock · 312 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · derivative · entry 9 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474 Underlying: capital stock · 139 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · derivative · entry 8 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613 Underlying: capital stock · 139 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 159 | $459.77 | $73,103.43 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · nonDerivative · entry 3 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,924 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 183 | $459.77 | $84,137.91 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · nonDerivative · entry 2 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2019 through December 31, 2021, compared to a defined peer group of companies. The Company's performance ranked in the 63rd percentile of that group, yielding an award of 130.26%; including the reinvestment of dividends paid during such period, the award is 131.6% of target. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 281 | $459.77 | $129,195.37 |
DisclosureSEC source: 0001209191-22-012036 · doc4.xml · nonDerivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2019 through December 31, 2021. The actual performance of 18.63% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 17:06 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 3,900 | $306.70 Strike: $306.70 | $1,196,130.00 |
DisclosureSEC source: 0001209191-21-064988 · doc4.xml · derivative · entry 10 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,646 Underlying: capital stock · 3,900 shares Expires 2023-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.